Literature DB >> 22696726

Balloon kyphoplasty treatment for a spontaneous vertebral fracture in renal osteodystrophy.

Andreas Demetriades1, Fabian Wong, Habib Ellamushi, Fari Afshar, John Yeh.   

Abstract

Renal osteodystrophy is a spectrum of musculoskeletal abnormalities. Bony fractures can occur spontaneously or with minor trauma in this condition. The authors report the first case of balloon kyphoplasty treatment for painful renal osteodystrophy vertebral body collapse secondary to end-stage renal failure on dialysis. The authors have demonstrated that kyphoplasty is a safe procedure for pain management in severe dystrophic patients. In addition, pain treatment with kyphoplasty can be achieved without anatomical restoration of vertebral body height.

Entities:  

Mesh:

Year:  2011        PMID: 22696726      PMCID: PMC3094774          DOI: 10.1136/bcr.02.2011.3890

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Percutaneous vertebroplasty with polymethylmethacrylate. Technique, indications, and results.

Authors:  H Deramond; C Depriester; P Galibert; D Le Gars
Journal:  Radiol Clin North Am       Date:  1998-05       Impact factor: 2.303

2.  Balloon kyphoplasty for vertebral compression fractures in solid organ transplant recipients: results of treatment and comparison with primary osteoporotic vertebral compression fractures.

Authors:  H Gordon Deen; Jaime Aranda-Michel; Ronald Reimer; David A Miller; John D Putzke
Journal:  Spine J       Date:  2006-07-24       Impact factor: 4.166

3.  Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial.

Authors:  Caroline A H Klazen; Paul N M Lohle; Jolanda de Vries; Frits H Jansen; Alexander V Tielbeek; Marion C Blonk; Alexander Venmans; Willem Jan J van Rooij; Marinus C Schoemaker; Job R Juttmann; Tjoen H Lo; Harald J J Verhaar; Yolanda van der Graaf; Kaspar J van Everdingen; Alex F Muller; Otto E H Elgersma; Dirk R Halkema; Hendrik Fransen; Xavier Janssens; Erik Buskens; Willem P Th M Mali
Journal:  Lancet       Date:  2010-08-09       Impact factor: 79.321

4.  Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.

Authors:  S Fletcher; R G Jones; H C Rayner; P Harnden; L D Hordon; J E Aaron; B Oldroyd; A M Brownjohn; J H Turney; M A Smith
Journal:  Nephron       Date:  1997       Impact factor: 2.847

5.  Risk factors for vertebral fractures in renal osteodystrophy.

Authors:  K Atsumi; K Kushida; K Yamazaki; S Shimizu; A Ohmura; T Inoue
Journal:  Am J Kidney Dis       Date:  1999-02       Impact factor: 8.860

Review 6.  Incidence of subsequent vertebral fracture after kyphoplasty.

Authors:  David Fribourg; Chris Tang; Parveen Sra; Rick Delamarter; Hyun Bae
Journal:  Spine (Phila Pa 1976)       Date:  2004-10-15       Impact factor: 3.468

7.  Fractures and vertebral bone mineral density in patients with renal osteodystrophy.

Authors:  B Piraino; T Chen; L Cooperstein; G Segre; J Puschett
Journal:  Clin Nephrol       Date:  1988-08       Impact factor: 0.975

8.  A randomized trial of vertebroplasty for osteoporotic spinal fractures.

Authors:  David F Kallmes; Bryan A Comstock; Patrick J Heagerty; Judith A Turner; David J Wilson; Terry H Diamond; Richard Edwards; Leigh A Gray; Lydia Stout; Sara Owen; William Hollingworth; Basavaraj Ghdoke; Deborah J Annesley-Williams; Stuart H Ralston; Jeffrey G Jarvik
Journal:  N Engl J Med       Date:  2009-08-06       Impact factor: 91.245

9.  A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.

Authors:  Rachelle Buchbinder; Richard H Osborne; Peter R Ebeling; John D Wark; Peter Mitchell; Chris Wriedt; Stephen Graves; Margaret P Staples; Bridie Murphy
Journal:  N Engl J Med       Date:  2009-08-06       Impact factor: 91.245

10.  Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial.

Authors:  Douglas Wardlaw; Steven R Cummings; Jan Van Meirhaeghe; Leonard Bastian; John B Tillman; Jonas Ranstam; Richard Eastell; Peter Shabe; Karen Talmadge; Steven Boonen
Journal:  Lancet       Date:  2009-02-24       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.